Causal prophylactic efficacy of atovaquone-proguanil (MalaroneTM) in a human challenge model

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 4, 2001, Pages 429-432

  Berman, J D ^a   Nielsen, R ^a   Chulay, J D ^b   Dowler, M ^a   Kain, K C ^c   Kester, K E ^a   Williams, J ^a   Whelen, A C ^a   Shmuklarsky, M J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Atovaquone proguanil; Chemoprophylaxis; Liver stages; Malaria; Plasmodium falciparum; Treatment duration

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; NAPHTHOQUINONE; PROGUANIL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; MIDDLE AGED; PARASITIC LIVER DISEASE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; LIVER DISEASES, PARASITIC; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; NAPHTHOQUINONES; TREATMENT OUTCOME;

EID: 0035409803     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90206-8     Document Type: Article

References (33)

1. Arnold, J. A., Alving, A. S. & Hockwald, R. S. (1955). The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama P-F-6 strain). Journal of Laboratory and Clinical Medicine, 46, 391-397.
2. Basco, L. K., Ramiliarisoa, O. & Le Bras, J. (1995). In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 53, 388-391.
3. Beerahee, M. (1999). Clinical pharmacology of atovaquone and proguanil hydrochloride. Journal of Travel Medicine, 6 (supplement 1), S13-S17.
4. Brueckner, R. P., Coster, T., Wesche, D. L., Shmuklarsky, M. & Schuster, B. G. (1998). Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial. Antimicrobial Agents and Chemotherapy, 42, 1293-1294.
5. Canfield, C. J., Pudney, M. & Gutteridge, W. E. (1995). Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Experimental Parasitology, 80, 373-381.
6. Chulay, J. D. (1998). Challenges in the development of antimalarial drugs with causal prophylactic activity. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 577-579.
7. Chulay, J. D., Schneider, I., Cosgriff, T. M., Hoffman, S. L., Ballou, W. R., Quakyi, I. A., Carter, R., Trosper, J. H. & Hockmeyer, W. T. (1986). Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 35, 66-68.
8. Davies, C. S., Pudney, M., Matthews, P. J. & Sinden, R. E. (1989). The causal prophylactic activity of the novel hydroxynaphthoquinone 566C80 against Plasmodium berghei infections in rats. Acta Leidensia, 58, 115-128.
9. DeAngelis, D. V., Long, J. D., Kanics, L. L. & Woolley, J. L. (1994). High-performance liquid Chromatographic assay for the measurement of atovaquone in plasma. Journal of Chromatography, 652, 211-219.
10. Diem, K. (1962). Documenta Geigy Scientific Tables. Ardsley, NY: Geigy Pharmaceuticals (p. 85).
11. Eriksson, B., Courtier, B., Björkman, A., Miltgen, F. & Mazier, D. (1991). Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 725-726.
12. Fairley, N. H. (1946). Researches on paludrine (M.4888) in malaria. An experimental investigation undertaken by the L.H.Q. Medical Research Unit (A.I.F.), Cairns, Australia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 40, 105-151.
13. Fisher, G. U., Gordon, M. P., Lobel, H. O. & Runcik, K. (1970). Malaria in soldiers returning from Vietnam. American Journal of Tropical Medicine and Hygiene, 19, 27-39.
14. Fleiss, J. L. (1981). Statistical Methods for Rates and Proportions, 2nd edn. Chichester: Wiley, pp. 44-46.
15. Fry, M. & Pudney, M. (1992). Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochemical Pharmacology, 43, 1545-1553.
16. Harinasuta, T., Bunnag, D., Lasserre, R., Leimer, R. & Vinijanont, S. (1985). Trials of mefloquine in vivax and of mefloquine plus 'Fansidar' in falciparum malaria. Lancet, i, 885-888.
17. Høgh, B., Clarke, P. D., Camus, D., Nothdurt, H. D., Overbosch, D., Günther, M., Joubert, I., Kain, K. C., Shaw, D., Roskell, N. S. & Chulay, J. D. (2000). Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune travellers: a randomised, double-blind study. Lancet, 356, 1888-1894.
18. Hussein, Z., Eaves, C. J., Hutchinson, D. B. & Canfield, C. J. (1996). Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. British Journal of Clinical Pharmacology, 42, 589-597.
19. Lell, B., Luckner, D., Ndjave, M., Scott, T. & Kremsner, P. G. (1998). Randomized placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet, 351, 709-713.
20. Lell, B., Faucher, J.-F., Missinou, M. A., Borrmann, S, Dangelmaier, O., Horton, J. & Kremsner, P. G. (2000). Malaria chemoprophylaxis with tafenoquine: a randomized study. Lancet, 355, 2041-2045.
21. Looareesuwan, S., Viravan, C., Webster, H. K., Kyle, D. E., Hutchinson, D. B. & Canfield, C. J. (1996). Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 54, 62-66.
22. Looareesuwan, S., Wilairatana, P., Chalermarut, K., Rattanapong, Y., Canfield, C. J. & Hutchinson, D. B. A. (1999a). Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 60, 526-532.
23. Looareesuwan, S., Chulay, J. D., Canfield, C. J. & Hutchinson, D. B. A. for the Malarone Clinical Trials Study Group (1999b). MalaroneTM (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. American Journal of Tropical Medicine and Hygiene, 60, 533-541.
24. Murphy, J. R., Baqar, S., Davis, J. R., Herrington, D. A. & Clyde, D. F. (1989). Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection. Journal of Clinical Microbiology, 27, 1434-1437.
25. Radloff, P. D., Philipps, J., Nkeyi, M., Hutchinson, D. & Kremsner, P. G. (1996). Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet, 347, 1511-1514.
26. Shanks, G. D., Gordon, D. M., Klotz, F. W., Aleman, G. M., Oloo, A. J., Sadie, D. & Scott, T. R. (1998). Efficacy and safety of atovaquone/proguanil for suppressive prophylaxis against Plasmodium falciparum malaria. Clinical Infectious Diseases, 27, 494-499.
27. Shanks, G. D., Kremsner, P. G., Sukwa, T. Y., van der Berg, J. D., Shapiro, T. A., Scott, T. R. & Chulay, J. D. (1999). Atovaquone and proguanil hydrochloride for prophylaxis of malaria. Journal of Travel Medicine, 6 (supplement 1), S21-S27.
28. Shapiro, T. A., Ranasinha, C. D., Kumar, N. & BarditchCrovo, P. (1999). Prophylactic activity of atovaquone against Plasmodium falciparum in humans. American Journal of Tropical Medicine and Hygiene, 60, 831-836.
29. Shmuklarsky, M. J., Boudreau, E. F., Pang, L. W., Smith, J. I., Schneider, I., Fleckenstein, L., Abdelrahim, M. M., Canfield, C. J. & Schuster, B. (1994). Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteers. Annals of Internal Medicine, 120, 294-299.
30. Shortt, H. E., Fairley, N. H., Covell, G., Shute, P. G. & Garnham, P. C. C. (1951). The pre-erythrocytic stage of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene, 44, 405-419.
31. Snounou, G., Viriyakosol, S., Jarra, W., Thaithong, S. & Brown, K. N. (1993). Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Molecular and Biochemical Parasitology, 58, 283-292.
32. Sukwa, T. Y., Mulenga, M., Chisdaka, N., Roskell, N. S. & Scott, T. R. (1999). A randomized, double-blind, placebocontrolled field trial to determine the efficacy and safety of MalaroneTM (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. American Journal of Tropical Medicine and Hygiene, 60, 521-525.
33. WHO (2000). International Travel and Health. Geneva: World Health Organization, pp. 67-85.